Why the study?
Does anesthesia with sevoflurane reduce the incidence of postoperative pneumonia compared to propofol in patients undergoing elective esophagectomy for cancer?
Does anesthesia with sevoflurane reduce the incidence of postoperative pneumonia compared to propofol in patients undergoing elective esophagectomy for cancer?
Sevoflurane and propofol are associated with similar rates of postoperative pneumonia when used for general anesthesia during esophagectomy.
Similar pneumonia rates do not favor either agent; leaves open optimal choice for esophagectomy patients.
BACKGROUND: Postoperative pneumonia (PP) is one of the common complications following esophagectomy and associated with poor short- and long-term outcomes. Sevoflurane and propofol, which have inflammatory-modulating effects, are common used general anesthetics. This study aimed to compare the effects of anesthesia with sevoflurane and propofol on the development of PP after esophageal surgery for cancer. METHODS: The electronic medical records of patients who underwent elective esophagectomy between July 2013 and July 2016 were reviewed. We conducted univariate and multivariate logistics analysis and propensity score matching analysis to compare the effect of sevoflurane and propofol on the incidence of PP and to identify the risk factors for PP after esophagectomy. RESULTS: Overall, the incidence of postoperative pneumonia was 9.5%. There was no significant difference in the rates of PP between sevoflurane group and propofol group either before or after propensity score matching (9.6% vs 8.0%, P = 0.606; 7.7% vs 6.4%, P = 0.754, respectively). Univariate and multivariate analysis revealed that alcohol use (OR 1.513; 95% CI 1.062-2.156), surgical procedure (Sweet: referent; Ivor-Lewis: OR 1.993; 95% CI 1.190-3.337; Three-incision: OR 1.878; 95% CI 1.296-2.722) and surgeon experience (high-volume: referent; low-volume: OR 1.525; 95% CI 1.090-2.135) were significant risk factors of postoperative pneumonia. CONCLUSIONS: Sevoflurane did not differ from propofol in terms of affecting the risk of PP development after esophagectomy.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: